Ligandal Inc., an early-stage genetic medicine biotechnology company, announced the appointment of Tushar Nuwal as Chief Operating Officer and Chief Business Officer.
Nuwal brings 20 years of biopharmaceutical experience, including positions with large and small pharmaceutical companies.
“We are delighted to welcome Tushar to Ligandal. His experience negotiating multi-billion dollar pharmaceutical transactions and his drive to scale the Ligandal platform will be invaluable to our growth,” said Andre Watson , President and CEO of Ligandal Inc.
Nuwal is a veteran of the global pharmaceutical industry. His leadership spans R&D, manufacturing, product and launch management, operations, corporate and business development, licensing, portfolio and commercial strategy. His most recent tenure was as Vice President of Polypid Inc., where he led business development and licensing (BD&L). Prior to that, he was Executive Director of BD&L at Sandoz, a $10 billion division of Novartis.
Nuwal’s career is marked by impressive achievements. He has successfully led and closed over $2 billion in deals and launched products generating over $1 billion in annual revenue. His experience includes positions at Pfizer Pharmaceuticals, Endo Pharmaceuticals, Purdue Pharma and Fresenius Kabi.
Nuwal holds a BA in Chemical Engineering and Economics from Rensselaer Polytechnic Institute , a Master’s in Transactional Law and Intellectual Property from Northwestern University , an MA in Finance from New York University , and is currently pursuing a certificate program in medical sciences at Harvard University .
“I am delighted to be joining Ligandal, advancing our cell and gene therapy platform. And particularly inspired by Andre Watson , our founder and ‘Forbes 30 under 30’ recipient in Healthcare. It is a pleasure to collaborate with him and our exceptional This team includes Dr. Adam Stein , our chief scientific officer and former mid-sized pharmaceutical executive, and Dr. Daniel Fagbuyi , board member, chief medical officer, former vice president of government affairs, former appointee of Obama Administration for Biodefense and Public Health, former adviser to HHS, FDA and CDC and a US Army war veteran. Together, we will scale the company’s vision and mission,” Nuwal revealed.
HrNxt.com Newsdesk has researchers and writers with an excellent domain knowledge about the talent ecosystem, and the business environment. The team keeps a tab on the latest happenings in the ecosystem to bring most relevant news and insights for our readers. You can connect with our newsdesk at newsdesk@hrnxt.com.